Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Posts 21-Percent Q3 Revenue Growth, Driven by Life and Lab Unit

NEW YORK, Oct. 27 (GenomeWeb News) - Thermo Electron yesterday reported a 21-percent surge in revenues for the third quarter, driven primarily by its Life and Laboratory Sciences segment.


Revenues for the quarter ended Sept. 30 totaled $542.3 million, up from $448.6 million during the same period last year. The company's Life and Laboratory Sciences unit, which includes mass spectrometry systems for proteomics research, booked $383.2 million in revenues--almost a third above the $301.8 million it took in during the same period last year. Revenues for the Measurement and Control unit increased to $159.1 million, from $145.6 million last year.


R&D expenses increased slightly, to $32.9 million from $30.4 million during the year-ago quarter.


Third-quarter earnings jumped to $106.5 million, or $.66 per basic share, from $48.5 million, or $.30 per basic share, for the year-ago period. This increase included a gain of $.40 per basic share from discontinued operations, primarily from the sale of its Spectra-Physics business, and tax benefits from another business sold previously.


Earnings per share from continuing operations totaled $.26 per share for the quarter, up from $.24 per share during last year's third quarter.


As of Oct. 2, Thermo had $335.7 million in cash and cash equivalents, and $90.2 million in short-term available-for-sale investments.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.